Delayed Graft Function clinical trials at UCSF
1 research study open to eligible people
Delayed graft function is when a donor kidney does not start working right away after transplant. UCSF is testing a new IV therapy to compare outcomes with standard care. UCSF is tracking urine, blood tests, and patient recovery for study results.
Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
open to eligible people ages 18 years and up
The primary objective of this study is to demonstrate the efficacy of ravulizumab vs placebo in reducing the severity of DGF as measured by time to freedom from dialysis in adult participants who are at high risk of DGF after undergoing transplant of deceased donor kidney.
San Francisco, California and other locations
Our lead scientists for Delayed Graft Function research studies include Flavio Vincenti.
Last updated: